prednisone has been researched along with Lambert-Eaton Myasthenic Syndrome in 9 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Lambert-Eaton Myasthenic Syndrome: An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. (From Adams et al., Principles of Neurology, 6th ed, pp 1471)
Excerpt | Relevance | Reference |
---|---|---|
"The prednisone dose was gradually reduced by 1 tablet every 2 weeks." | 1.48 | Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report. ( Guan, H; Hao, Y; Li, H; Lv, Z; Zhang, A, 2018) |
"The case of a patient with fatigable diplopia and ptosis 3 years after removal of a large-cell lung carcinoma is presented." | 1.31 | Myasthenia gravis with a paraneoplastic marker. ( Leavitt, JA, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Gill, AJ | 1 |
Gandhy, S | 1 |
Lancaster, E | 1 |
Portaro, S | 1 |
Brizzi, T | 1 |
Sinicropi, S | 1 |
Cacciola, A | 1 |
De Cola, MC | 1 |
Bramanti, A | 1 |
Milardi, D | 1 |
Lupica, A | 1 |
Bramanti, P | 1 |
Toscano, A | 1 |
Rodolico, C | 1 |
Li, H | 1 |
Zhang, A | 1 |
Hao, Y | 1 |
Guan, H | 1 |
Lv, Z | 1 |
Kostera-Pruszczyk, A | 1 |
Ryniewicz, B | 1 |
Rowinska-Marcinska, K | 1 |
Dutkiewicz, M | 1 |
Kamińska, A | 1 |
Guevara, C | 1 |
Pedraza, L | 1 |
Idiáquez, J | 1 |
Delgado, M | 1 |
Leavitt, JA | 1 |
Homenda, W | 1 |
Hellmann, A | 1 |
Sieb, JP | 1 |
Dengler, R | 1 |
Jerusalem, F | 1 |
Jost, WH | 1 |
Mielke, U | 1 |
Schimrigk, K | 1 |
9 other studies available for prednisone and Lambert-Eaton Myasthenic Syndrome
Article | Year |
---|---|
Nivolumab-associated Lambert-Eaton myasthenic syndrome and cerebellar dysfunction in a patient with a neuroendocrine tumor.
Topics: Amifampridine; Antineoplastic Combined Chemotherapy Protocols; Calcium Channels, P-Type; Calcium Cha | 2021 |
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports.
Topics: 4-Aminopyridine; Activities of Daily Living; Adult; Amifampridine; Azathioprine; Drug Therapy, Combi | 2017 |
Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report.
Topics: Anti-Inflammatory Agents; Antibodies; Encephalitis; Hashimoto Disease; Humans; Hydrolases; Immunoglo | 2018 |
Lambert-Eaton myasthenic syndrome in childhood.
Topics: Autoantibodies; Azathioprine; Calcium Channels, P-Type; Child; Humans; Immunosuppressive Agents; Lam | 2009 |
[Idiopathic Lambert-Eaton myasthenic syndrome: report of one case].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Humans; Immunosuppressive Agents; Lambert-Eaton Myast | 2006 |
Myasthenia gravis with a paraneoplastic marker.
Topics: Autoantibodies; Azathioprine; Biomarkers; Blepharoptosis; Calcium Channels; Carcinoma, Large Cell; D | 2000 |
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Humans; Lam | 2000 |
[Non-neoplastic Lambert-Eaton syndrome. A frequently missed diagnosis?].
Topics: Adult; Azathioprine; Diagnosis, Differential; Electric Stimulation; Female; Humans; Lambert-Eaton My | 1992 |
Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.
Topics: 4-Aminopyridine; Amifampridine; Combined Modality Therapy; Electromyography; Follow-Up Studies; Guan | 1991 |